PMC:2817507 / 17947-18288 JSONTXT 21 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T8593 0-2 IN denotes In
T8594 3-13 NN denotes conclusion
T8595 13-14 , denotes ,
T8596 15-18 DT denotes the
T8597 19-26 JJ denotes present
T8598 27-32 NN denotes study
T8599 33-45 VBD denotes demonstrated
T8600 46-49 DT denotes the
T8601 50-58 JJ denotes temporal
T8602 59-66 NN denotes profile
T8603 67-69 IN denotes of
T8604 70-73 DT denotes the
T8605 74-84 NN denotes activation
T8606 85-87 IN denotes of
T8607 88-101 JJ denotes TLR4-mediated
T8608 102-106 NNP denotes NFκB
T8609 107-116 VBG denotes signaling
T8610 117-119 IN denotes in
T8611 120-125 NN denotes brain
T8612 126-132 NN denotes tissue
T8613 133-135 IN denotes in
T8614 136-137 DT denotes a
T8615 138-141 NN denotes rat
T8616 142-147 NN denotes model
T8617 148-150 IN denotes of
T8618 151-163 JJ denotes experimental
T8619 164-167 NNP denotes ICH
T8620 167-168 , denotes ,
T8621 169-174 WDT denotes which
T8622 175-183 VBZ denotes suggests
T8623 184-188 IN denotes that
T8624 189-202 JJ denotes TLR4-mediated
T8625 203-207 NNP denotes NFκB
T8626 208-217 VBG denotes signaling
T8627 218-230 VBZ denotes participates
T8628 231-233 IN denotes in
T8629 234-237 DT denotes the
T8630 238-250 NN denotes pathogenesis
T8631 251-253 IN denotes of
T8632 254-257 NNP denotes ICH
T8633 257-258 , denotes ,
T8634 259-264 WDT denotes which
T8635 265-268 MD denotes may
T8636 269-271 VB denotes be
T8637 272-273 DT denotes a
T8638 274-285 JJ denotes therapeutic
T8639 286-292 NN denotes target
T8640 293-296 IN denotes for
T8641 297-300 DT denotes the
T8642 301-311 NN denotes prevention
T8643 312-314 IN denotes of
T8644 315-326 JJ denotes ICH-induced
T8645 327-332 NN denotes brain
T8646 333-339 NN denotes damage
T8647 339-340 . denotes .
R6744 T8593 T8599 prep In,demonstrated
R6745 T8594 T8593 pobj conclusion,In
R6746 T8595 T8599 punct ",",demonstrated
R6748 T8596 T8598 det the,study
R6749 T8597 T8598 amod present,study
R6751 T8598 T8599 nsubj study,demonstrated
R6752 T8599 T8599 ROOT demonstrated,demonstrated
R6753 T8600 T8602 det the,profile
R6754 T8601 T8602 amod temporal,profile
R6756 T8602 T8599 dobj profile,demonstrated
R6757 T8603 T8602 prep of,profile
R6758 T8604 T8605 det the,activation
R6760 T8605 T8603 pobj activation,of
R6761 T8606 T8605 prep of,activation
R6763 T8607 T8608 compound TLR4-mediated,NFκB
R6764 T8608 T8606 pobj NFκB,of
R6765 T8609 T8602 acl signaling,profile
R6766 T8610 T8609 prep in,signaling
R6768 T8611 T8612 compound brain,tissue
R6769 T8612 T8610 pobj tissue,in
R6772 T8613 T8612 prep in,tissue
R6774 T8614 T8616 det a,model
R6775 T8615 T8616 compound rat,model
R6776 T8616 T8613 pobj model,in
R6777 T8617 T8616 prep of,model
R6778 T8618 T8619 amod experimental,ICH
R6779 T8619 T8617 pobj ICH,of
R6781 T8620 T8619 punct ",",ICH
R6782 T8621 T8622 nsubj which,suggests
R6784 T8622 T8602 relcl suggests,profile
R6785 T8623 T8627 mark that,participates
R6786 T8624 T8625 compound TLR4-mediated,NFκB
R6787 T8625 T8627 nsubj NFκB,participates
R6789 T8626 T8625 acl signaling,NFκB
R6790 T8627 T8622 ccomp participates,suggests
R6792 T8628 T8627 prep in,participates
R6793 T8629 T8630 det the,pathogenesis
R6794 T8630 T8628 pobj pathogenesis,in
R6795 T8631 T8630 prep of,pathogenesis
R6797 T8632 T8631 pobj ICH,of
R6798 T8633 T8632 punct ",",ICH
R6799 T8634 T8636 nsubj which,be
R6801 T8635 T8636 aux may,be
R6802 T8636 T8630 relcl be,pathogenesis
R6803 T8637 T8639 det a,target
R6805 T8638 T8639 amod therapeutic,target
R6806 T8639 T8636 attr target,be
R6809 T8640 T8639 prep for,target
R6811 T8641 T8642 det the,prevention
R6812 T8642 T8640 pobj prevention,for
R6813 T8643 T8642 prep of,prevention
R6815 T8644 T8646 amod ICH-induced,damage
R6816 T8645 T8646 compound brain,damage
R6817 T8646 T8643 pobj damage,of
R6819 T8647 T8599 punct .,demonstrated